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Introduction
The selection of healthy donors is crucial to maintain the exist-
ing high level of blood safety. Thus, the donor questionnaire (DQ) 
becomes an important part of the donor selection process. In 
 Germany, at present, different questionnaires are in use due to the 
de-centralized structure of the blood supply [1]. All DQs fulfil the 
criteria required by the German Hemotherapy Guidelines and reg-
ulations of the competent authority [2]. To optimize the quality of 
the DQ, a group on behalf of the National Advisory Committee 
‘Blood’ developed a uniform DQ (UDQ) which aimed to be as sim-
ple as possible, comprehensible, accepted by donors, and effective 
in selecting low-risk healthy donors [1, 3]. Special attention was 
paid to (hetero-)sexual risk behavior. A new question on unpro-
tected sexual contact with a new partner within the 4 months pre-
ceding the donation was introduced. Results of a first evaluation of 
the newly developed UDQ showed that especially young male first-
time donors were deferred due to a new sexual partner [3]. This 
raised the concern that many donors, including repeat donors, 
could be lost if the UDQ become mandatory, especially within the 
younger donor population. This concern was addressed in a sec-
ond multicenter trial with a larger sample size including first-time 
and repeat donors. 
The goal of this study was to determine the effect of the UDQ 
on deferral rates in first-time and repeat donors. We focused on 
the effects of the newly introduced question about unprotected 
sexual contact with a new partner. In a second step, we made a 
stratified comparison of deferral rates between the UDQ and the 
DQ.
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Summary
Background: We assessed the effect of the uniform 
donor questionnaire (UDQ) on deferral rates in first-time 
and repeat donors. We focused on the introduced ques-
tion about unprotected sexual contact with a new part-
ner. Another goal was a stratified comparison of the de-
ferral rates of the donor questionnaire (DQ) and UDQ. 
Methods: Data on donors and deferrals using the DQ 
and UDQ were collected at four blood establishments. 
The comparison included a 2-year period by question-
naire version. For the comparison of the questionnaires, 
an adjusted multinomial logistic regression was per-
formed. Results: The analysis included 260,848 dona-
tions. First-time (FTD) and repeat donations (RD) showed 
higher deferral rates with the UDQ (FTD +5.4%, RD 
+1.4%). Deferral due to a new partner was 3.0% in first-
time and 0.4% in repeat donors. The majority of these 
occurred in the youngest age groups. The most frequent 
deferral criterion was ‘disease’ (5.1%). Conclusion: The 
regression revealed stronger predictors for deferral than 
the questionnaire version. Especially younger age car-
ried a higher and independent risk for deferral. The ad-
ditional deferrals of mainly young first-time donors due 
to a new sexual partner may identify those donors with 
potential heterosexual risk behavior who would other-
wise not be identified.
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Material and Methods
Call for Participants
All blood establishments (BE) in Germany were invited to participate in the 
study via the homepage of the National Competent Authority (Paul Ehrlich In-
stitute). Different levels of data entry for deferrals were offered to the partici-
pants of the study. All data were stratified for sex, age group (18–24 years; 
25–34 years; 35–44 years; 45–54 years; >54 years), and donor status (first-time 
or repeat donor).
The following levels of data entry were used by the BE which participated in 
the study: 
1) Deferrals were reported on an individual level differentiating between tem-
porary and permanent deferrals. Reasons for deferral were summed in ten 
categories: disease (which included surgery, medication, vaccination, and all 
types of medical treatment or underlying conditions); risk for Creutzfeldt-
Jacob disease (CJD) and variant CJD; pregnancy and breast feeding; physical 
examination; travel-associated risks; sexual risk behavior (except for new 
partner); unprotected sexual contact with a new partner within the 4 months 
preceding the donation; injecting drug use; tattoo, piercing, needle stick in-
jury; other reasons. 
2) Deferrals were reported as aggregated data. Within this level of data entry, 
five categories for deferral (new partner, disease, travel-associated, tattoos, 
and sexual risk behavior) were used. These data were also stratified for sex, 
age group, and donor status. 
Both levels included the number of successful donations and the number of 
confidential unit exclusions (CUE) stratified for sex, age group, and donor 
status.
Study Participants
Our multicenter study was conducted between 2009 and 2013 at the follow-
ing four BE: German Red Cross Blood Service West, Hagen (BSD West); De-
partment for Transfusion Medicine, University of Greifswald; Institute for Im-
munology and Transfusion Medicine, Medical University Gießen and Marburg; 
Institute for Laboratory Medicine and Transfusion Medicine, Helios Hospital 
Pforzheim.
All BE submitted their data generated using the UDQ. In addition, two BE 
(BSD West, Gießen/Marburg) added comparative data using the DQ (table 1). 
Retrospectively, BSD West submitted data sets based on the 2 years preceding 
the study when the established DQ was used. 
Statistical Analyses
The analysis was based on donations. The aggregated data on successful 
donations were imputed to individual data. Differences on descriptive level 
were analyzed with the chi-square test according to Pearson. Throughout sta-
tistical analyses, we aggregated temporary and permanent deferral into one 
deferral variable. We excluded CUE cases from any regression analyses. To 
further investigate the contribution of the newly introduced category ‘new 
partner’, we performed multinomial logistic regression. We employed multi-
nomial logistic regression analysis to estimate deferral within the UDQ in the 
following categories: new partner, disease, tattoos, and other reasons depend-
ing on sex and age group. The base outcome was successful donation. Interac-
tions between sex and age group were included to characterize possible risks 
for deferral. We adjusted regression analysis for sex, age group, and donor sta-
tus. For sex, age group, and donor status, we used donations from female do-
nors, age group 35–44 years, and donations from repeat donors as reference 
categories. Since we found an overall effect of first-time donation, we limited 
the model to repeat donations and adjusted it for sex and age group as de-
scribed above. 
For the comparison of DQ and UDQ, one BE (BSD West) gathered infor-
mation fit for the adjusted multinomial logistic regression. The comparison of 
DQ and UDQ was adjusted with regard to sex, age group, and questionnaire 
version (DQ as reference category). The comparison did not include the defer-
ral category ‘new partner’ since this category did not exist in the established 
DQ. All regression results are reported in relative risks and their significant 
contribution to the model. We compared 2 years with the DQ versus 2 years 
with the UDQ. P values < 0.05 were considered significant. 
All analyses were performed using STATA® 14.1 (StataCorp LP, College 
Station, TX, USA).
Results
Of all participating BE, data of 261,016 donations entered the 
study. Missing data summed up to 0.1% of the total sample size. All 
remaining 260,848 donations were included into the analysis 
(99.9%). These included 145,965 (55.9%) donations collected with 
the UDQ. Two sites applied both questionnaires (BSD West and 
Gießen/Marburg). At the BSD West the UDQ rate was 49.1%, and 
at Giessen/Marburg it was 39.0% of all donations.
Descriptive Analysis
The deferral rate in the four study sites ranged from 9.4% in re-
peat donations to 34.7% in first-time donations. A CUE was made 
in 0.3% of all donations, irrespective of donor status. Details are 
presented in table 2.
Reasons for Deferral
Of all deferral categories applied in this study, ‘disease’ showed 
the highest deferral rate in first-time (13.8%) and repeat donations 
(3.7%). Deferral rates for all categories are listed in table 3.
Study site Questionnaire Time period
BSD West DQ 16.05.2009–15.05.2011
UDQ 16.05.2011–15.05.2013
Gießen/Marburg DQ 18.04.–23.05., 06.06.–10.06.2011
UDQ 24.05.–02.06., 14.06.–21.06., 08.07.–13.07.2011
Greifswald UDQ 01.06.2011–31.12.2011
Pforzheim UDQ 01.10.2011–31.12.2012
Table 1. Overview of the period and question-
naires applied by study participants
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The two youngest age groups revealed the highest deferral due 
to a new partner: 2.1% (531/25,403) of all donations of 18- to 
24-year-old donors and 1.4% (452/32,050) of all donations of 25- 
to 34-year-old donors were deferred. Stratified for donor status, 
deferrals of male first-time donors were significantly higher than 
deferrals of female first-time donors within the same age groups 
(18- to 24-year-old donors: chi-square (1) = 35.5; p < 0.01; 25- to 
34-year-old donors: chi-square (1) = 34.0; p < 0.01) Details are 
shown in figure 1. 
Multinomial Logistic Regression Model 
The adjusted multinomial logistic regression model to identify 
risk factors for deferral showed an overall effect of first-time dona-
tions (chi-square (5) = 5748.93, p < 0.01). Therefore, we limited the 
model to repeat donations, which constitute 86.1% of all donations 
applying the UDQ (125,615/145,965). 
Relative Risks of Deferral due to Newly Introduced Category 
‘New Partner’
Results of the final model revealed: Donations of the two young-
est age groups had a three (18–24 years) and two times (25–34 
years) higher expected risk of exclusion due to ‘new partner’ (RR18–
24 years = 3.06, p < 0.01; RR 25–34 years = 2.45, p < 0.01). The two oldest 
age groups had significantly lower expected risks of being deferred 
by indicating unprotected intercourse with new sexual partner 
within the preceding 4 months (RR45–54 years = 0.38, p < 0.01; RR>54 
years = 0.08, p < 0.01). Neither sex nor the interaction of sex and age 
group significantly contributed to the estimation of deferral in the 
category ‘new partner’ regarding repeat donations.
Influence of Sex
Within the categories ‘disease’, ‘tattoos’, and ‘other’, female do-
nors had an expected higher risk of deferral (disease: RRmale = 
0.67, p < 0.01; tattoos: RRmale = 0.45, p < 0.01; other: RRmale = 0.48, 
p < 0.01). 
Study site Donor status Total Deferral (%) CUE (%) Successful donations (%)
BSD West FTD 17,423 6,619 (38.0) 38 (0.2) 10,766 (61.8)
RD 90,907 10,107 (11.1) 302 (0.3) 80,498 (88.6)
Marburg FTD 230 22 (10.5) 2 (0.9) 206 (89.6)
RD 1,500 32 (2.1) 4 (0.3) 1,464 (97.6)
Greifswald FTD 1,523 301 (19.8) 15 (1.0) 1,207 (79.3)
RD 17,216 1,329 (7.7) 48 (0.3) 15,839 (92.0)
Pforzheim FTD 1,174 193 (16.4) 0 (0.0) 981 (83.6)
RD 15,992 316 (2.0) 1 (0.0) 15,675 (98.0)
All
FTD 20,350 7,135 (34.7) 55 (0.3) 13,160 (64.7)
RD 125,615 11,784 (9.4) 355 (0.3) 113,476 (90.3)
all 145,965 18,919 (13.0) 410 (0.3) 126,636 (86.8)
FTD = First-time donation; RD = repeat donation; CUE = confidential unit exclusion.
Table 2. Deferrals 
with the UDQ by 
study site and donor 
status (n = 145,965)
Deferral category Donor status
FTD (%) RD (%) All (%) 
Successful donation 13,160 (64.7) 113,476 (90.3) 126,636 (86.8)
Disease 2,809 (13.8) 4,588 (3.7) 7,397 (5.1)
Examination 1,522 (7.5) 3,973 (3.2) 5,495 (3.8)
Tattoos 1,057 (5.2) 737 (0.6) 1,794 (1.2)
New partner 616 (3.0) 532 (0.4) 1,148 (0.8)
Travel associated 149 (0.7) 302 (0.2) 451 (0.3)
Injecting drug use# 167 (0.8) 59 (0.1) 226 (0.2)
Sexual risk behavior 79 (0.4) 41 (0.0) 120 (0.1)
Pregnancy# 55 (0.3) 52 (0.0) 107 (0.1)
CJD/ vCJD# 28 (0.1) 13 (0.0) 41 (0.0)
Other# 653 (3.2) 1,487 (1.2) 2,140 (1.5)
Total 20,355 (100.0) 125,615 (100.0) 145,965 (100.0)
FTD = First-time donation; RD = repeat donation; # Not reported by Gießen/Marburg.
Table 3. Descriptive of deferral categories of the 
UDQ (n = 145,965)
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Influence of Age Group
As in the category ‘new partner’, we found in ‘tattoos’ and 
‘other’ a highly significant expected risk of the two youngest age 
groups to be deferred (tattoos: RR18–24 years = 2.06, p < 0.01; RR25–34 
years = 1.47, p < 0.01; other: RR18–24 years = 1.79, p < 0.01; RR25–34 years 
= 1.57; p < 0.01) while the two oldest age groups showed a highly 
significant lower expected risk to be deferred within these catego-
ries (tattoos: RR45–54 years = 0.51, p < 0.01; RR>54 years = 0.22, p < 
0.01; other: RR45–54 years = 0.76, p < 0.01; RR>54 years = 0.63, p < 0.01). 
In contrast to these results, within the category ‘disease’ only dona-
tions of 25- to 34-year-old donors have a higher expected risk for 
deferral due to ‘disease’ (disease: RR25–34 years = 1.33, p < 0.01).
For all categories, we found interactions between sex and age 
group in the category ‘other’ only; indicating lower risks for defer-
ral due to ‘other’ in donations of men within the two youngest age 
groups (other: RRmale*18–24 years = 0.72, p < 0.01; RRmale*25–34 years = 
0.70; p < 0.01). Donations of men within the eldest age group show 
higher expected risk for deferral within the category ‘other’ 
(RRmale*>54 years = 1.80, p < 0.01).
Comparison of the DQ and the UDQ 
Of 260,848 data sets, 219,559 (84.2%) were from one BE (BSD-
West) using both questionnaire versions and all deferral categories 
each over a 2-year period: 112,176 (51.1%) with the DQ and 
107,383 (48.9%) with the UDQ (table 4).
Female donors were more often deferred than male donors in 
both questionnaires (UDQ: female 19.7% vs. male: 12.2%; chi-
square (1) = 1,300; p < 0.01; DQ: female 16.8% vs. male 9.9%; chi-
square (1) = 1,200; p < 0.01). However, there were no sex differ-
ences in deferrals between questionnaire versions (chi-square (1) = 
0.00; p > 0.05). 
The overall deferral rate increased with the UDQ by 1.8%. Espe-
cially, first-time donors had a 5.4% higher deferral rate (table  5). 
This is mainly attributed to the deferral category ‘disease’. Deferrals 
due to pregnancy, travel, and sexual risk behavior, increased by less 
than 0.3% with the UDQ. CUE did not differ between questionnaire 
versions (chi-square (1) = 0.02; p > 0.05); irrespective of donor sta-
tus. However, in both questionnaires male first-time donors used 
CUE more frequently than female first-time donors (UDQ: chi-











Female 42.0 43.7 42.2 44.0
Age groups (%)
18–24 years  1.9  6.1  7.8** 13.8**
25–34 years 22.2 26.7 19.6** 21.2**
34–44 years 11.9 11.5 12.0 11.7
45–54 years 24.8 22.1 24.8 22.3
>54 years 39.2 33.7 35.7** 31.0**
DQ = Donor questionnaire; UDQ = uniform DQ; RD = repeat donation; **p < 0.01.
Table 4. Sociodemographic characteristics  
(n = 219,559)
Table 5. Deferrals according to the UDQ versus DQ by donor status (excluding category ‘new partner’) (n = 219,559)
Deferral category DQ (n=112,176) UDQ (n=107,383)
FTD RD all FTD RD all
Disease 2,112 (11.10) 2,911 (3.13) 5,023 (4.48) 2,594 (15.37) 4,138 (4.57) 6,732 (6.27)
Examination 1,555 (8.15) 3,210 (3.45) 4,765 (4.25) 1,412 (8.37) 3,210 (3.55) 4,622 (4.30)
Other 629 (3.30) 1,4321 (1.54) 2,060 (1.84) 576 (3.41) 1,283 (1.42) 1,859 (1.73)
Tattoos 1,115 (5.86) 709 (0.76) 1,824 (1.63) 1,037 (6.15) 683 (0.75) 1,720 (1.60)
Travel 91 (0.48) 239 (0.26) 330 (0.29) 131 (0.78) 251 (0.28) 382 (0.36)
IDU 162 (0.85) 38 (0.44) 200 (0.18) 166 (0.98) 59 (0.07) 225 (0.21)
Sexual risk 57 (0.30) 18 (0.21) 75 (0.07) 72 (0.43) 29 (0.03) 101 (0.09)
Pregnancy 48 (0.25) 68 (0.07) 116 (0.10) 54 (0.32) 46 (0.05) 100 (0.09)
CJD/vCJD 51 (0.27) 22 (0.02) 73 (0.07) 27 (0.16) 11 (0.01) 38 (0.04)
Total deferral 5,820 (30.6) 8,646 (9.3) 14,466(12.9) 6,069 (36.0)** 9,710 (10.7)** 15,779 (14.7)**
CUE 43 (0.2) 340 (0.4) 383 (0.3) 38 (0.2)n.s. 302 (0.3)n.s. 340 (0.3)n.s.
Total donations 19,035 (100) 93,141(100) 112,176 (100) 16,873 (100) 90,510 (100) 107,383 (100)
DQ = Donor questionnaire; UDQ = uniform DQ; FTD = first-time donation; RD = repeat donation; CUE = confidential unit exclusion; IDU = injecting drug use; 
** p < 0.01; n.s. = not significant.
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Adjusted Multinomial Logistic Regression 
Adjusted multinomial logistic regression was confined to the 
group of repeat donations due to an overall effect of first-time do-
nors (chi-square (4) = 6284.87, p < 0.01; 80.4% (176,589/219,559). 
Influence of Questionnaire Version
Donors using the UDQ had a higher expected risk of deferral in 
the category ‘disease’ (RRUDQ = 1.5; p < 0.01) than donors using 
the DQ regardless of age and sex. On the other hand, donors using 
the DQ had a higher expected risk of deferral in the categories ‘tat-
toos’ (RRUDQ = 0.87, p < 0.01) and ‘other’ (RRUDQ = 0.92, p < 0.01) 
independent of age and sex.
Influence of Sex
Women showed significantly higher expected risks for deferral 
in the categories ‘disease’ and ‘tattoos’ independent of question-
naire version and age group (disease: RRmale = 0.72, p < 0.01; tat-
toos: RRmale = 0.59, p < 0.01). 
Influence of Age Group
In almost all categories the two youngest age groups were at a 
higher expected risk of exclusion independent of sex and question-
naire version (disease: RR18–24 years = 1.2, p > 0.05; RR25–34 years = 
1.2, p < 0.01; tattoos: RR18–24 years = 3.6, p < 0.01; RR25–34 years = 2.0, 
p < 0.01; other: RR18–24 years = 1.5, p < 0.01; RR25–34 years = 1.2, 
p < 0.05), whereas donations of the two oldest age groups were less 
likely to be excluded (disease: RR45–54 years = 0.9, p < 0.05; RR>54 years 
= 0.8, p < 0.01; tattoos: RR45–54 years = 0.6, p < 0.01; RR>54 years = 0.2, 
p < 0.01; other: RR45–54 years = 0.7, p < 0.01; RR>54 years = 0.7, p < 01).
Influence of Sex and Age Group
Within the category ‘disease’ men aged 18–24 years were at risk 
for deferral (RRmale*18–24 years = 1.3, p < 0.05). 
Discussion
Donor selection is an important step in maintaining the high 
level of safety for donor and recipient. The presented study as-
sessed deferral rates in first-time and repeat donors when a re-
cently developed uniform UDQ was used. We focused on the effect 
of the introduced question about a new sexual partner. Addition-
ally, we compared the UDQ with the established DQ. 
We found an overall deferral rate of 13.0% with the new UDQ. 
This rate was similar to comparable studies: In the literature, about 
10–15% of applicant donors are deferred due to the DQ [4–6]. Still, 
in comparison to the established DQ, we found an increase in de-
ferrals by 5.4% and 1.4% in first-time and repeat donations respec-
tively. These additional deferrals were mainly due to higher defer-
ral rates in the category ‘disease’. This corresponds well to the re-
sults of the previous DQ study in which the UDQ was evaluated in 
a multicenter trial with 6,500 first-time donors [3]. The category 
‘disease’ included medical treatment of any kind or underlying 
medical conditions. Donor deferral due to this category is intended 
to reduce the risk of undetected transfusion-transmissible infec-
tions (TTI) or to assure donor health [7, 8]. Therefore, we consider 
the moderate increase in deferrals due to medical treatment or 
conditions to be of benefit with respect to blood and donor safety. 
An essential innovation in the UDQ was the introduction of a 
question regarding unprotected intercourse with a new sexual 
partner in the 4 months preceding the donation. This question ad-
dressed heterosexual risk behavior as sex between men lead to a 
permanent deferral according to the German Hemotherapy Guide-
lines [2]. In recent analyses, undisclosed heterosexual contacts re-
vealed to be a risk factor for TTI (Preußel, personal communica-
tion; [9–12]). In Germany, an analysis demonstrated that unre-
ported heterosexual risks were more prevalent in HIV- or HCV-
infected blood donors than in cases from the general population 
(Preußel, personal communication). According to this study, the 
identification of all heterosexual risk contacts might prevent ac-
ceptance of 53% of HIV-infected donors. A further study of undis-
closed risk behavior in HIV-positive donors in Italy revealed het-
erosexual risk contacts in 68.1% [9]. Another retrospective analysis 
of pre-donation screening revealed acute HBV infections in donors 
reporting new heterosexual partners [11]. Also in the UK, there 
were more reported heterosexual exposures among infected blood 
donors (both with and without a partner with an identifiable risk) 
in 2014 than in the previous year, while other reported exposure 
like sex between men decreased [12]. The UK blood donor surveil-
lance report showed that 18 of 24 donors with a recent infection 
were infected by heterosexual contacts. Of these, 4 male and 3 fe-
male donors reported one or more new partners. Also, like in Ger-
many, a rise in recent syphilis infections among new donors, espe-
cially heterosexual men, was observed in the UK [12]. The rise was 
most prominent in young male donors but also seen – to a lesser 
extent – in young female donors, which could imply a rise in (het-
ero-)sexual risk behavior. 
Heterosexual risk behavior was addressed in former DQs using 
leading questions about, e.g., ‘one-night stands’, ‘casual contacts’, 
or ‘frequent change of partner’. These questions partly left the risk 
assessment to the donor. However, recent studies confirmed that 
in post-donation interviews, the majority of HIV-positive donors 
did not realize they engaged in risk behavior [9, 10, 13]. Therefore, 
a precise definition of heterosexual risk behavior would be desira-
ble. Attempts to make this definition failed with exception of high-
risk behavior like sex work [14]. Therefore, in the conception of the 
UDQ, we decided to address heterosexual exposure (unprotected 
sexual contact with a new partner prior to the donation) rather 
than making an arbitrary definition of heterosexual risk behavior. 
This procedure is well established in other countries like Spain or 
Italy [14]. Further advantages of this approach are that a question 
about sexual contact with a new partner is clear and non-judgmen-
tal and leaves little room for interpretation by the donor [3]. 
The question about a new sexual partner chiefly lead to deferrals 
of younger first-time donors: On the descriptive level, we found 
significantly higher deferral rates in the ‘new partner’ category 
among male first-time and – to a lesser extent– among repeat do-
nors. If we are controlling for the large sample size by using effect 
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sizes, i.e. relative risks, provided by a multinomial logistic regres-
sion analysis [15], the indications of higher deferral rates of young 
male donors did not achieve significance in repeat donations. The 
multinomial logistic regression showed higher risks for exclusion 
due to a new sexual partner in the two youngest age groups, inde-
pendent of sex. The ‘new partner’ question identified the group 
which empirically carries the highest risk for TTIs [16]. Thus the 
‘new partner’ question is capable of preventing window period do-
nations of donors with unspecified heterosexual risks. 
Still, demographic changes in Germany will most likely lead to 
fewer younger donors in the future on the one hand and to an in-
creasing need of blood and blood products due to an ageing popu-
lation on the other [17, 18]. Therefore, the reasons for deferral 
need to be clearly communicated to potential donors, and low-risk 
donors should be recruited continuously in order to provide 
enough appropriate blood products for patients in need. The re-
cently published first results of the ‘donor of the future project’ also 
addressed demographic changes of the donor population and 
showed the need for new service strategies for future donor recruit-
ment in order to meet the high expectations of donors [19]. Ulti-
mately, the safety gained by rigid and straightforward donor selec-
tion for sexual risks must not lead to a disproportional loss of re-
cruited and retained young repeat donors. 
In the first UDQ study [3], some donors felt that the character 
of direct questions about their sexual contacts were too private. 
Nonetheless, the UDQ was acceptable to the majority of donors 
[17] and demonstrated its superiority compared to the established 
DQ regarding comprehensibility as well as donor adherence [3]. 
Furthermore, results of a cognitive interview evaluation of the new 
AABB DQ found no evidence that blood donors modified their an-
swers due to a perceived inappropriate sensitive character of ques-
tions [10]. 
The comparison of questionnaire versions did not include the 
‘new partner’ question as it was not asked in the DQ. In the com-
parative analysis of the remaining categories, the only significant 
influence of the UDQ on deferral rates was found in the category 
‘disease’. This was demonstrated on the descriptive level in a previ-
ous study [20]. Our regression analysis revealed that the observed 
higher deferral rates in the category ‘disease’ were independent of 
age and sex. The data available for this study did not allow for anal-
ysis of underlying reasons for deferral in any category. Still, a com-
parison of the questionnaires showed that in the DQ almost all 
medical reasons for deferral were asked in one grouped question. 
In contrast with the UDQ, it was initially asked whether the donor 
is feeling sick or is on sick leave. This was followed by a set of 
grouped questions regarding medical conditions. Furthermore, 
with the UDQ it was explicitly asked about certain commonly used 
drugs, i.e. acetylsalicylic acid. Similar reasons for higher deferral 
rates with the DQ in the category ‘tattoos’ can be assumed. With 
the DQ, tattoo, piercing, and needle stick injury were asked in one 
grouped question with acupuncture, colonoscopy as well as contact 
to a patient with hepatitis. In contrast to the DQ, the UDQ in-
cluded separate questions to tattoo, piercing, and needle stick in-
jury. These differences in layout and questions may have led to the 
above mentioned differences in deferral rates between the two 
questionnaire versions and warrant further investigations. 
Overall, female donors were more often deferred than male with 
both questionnaires. This has also been observed in other investi-
gations [20, 21]. However, the regression analysis showed that 
women were not significantly more often deferred with the UDQ. 
Also, in almost all categories for deferral the two youngest age 
groups were at a higher risk of deferral independent of sex and 
questionnaire version. These results from the regression analyses 
differed from the results of a previous DQ study [20]. 
There are limitations with regard to our study: Due to the cate-
gorization of reasons for deferral, we were unable to specify precise 
differences in deferrals. This applied especially to the category ‘dis-
ease’ which includes all types of medical treatment or underlying 
conditions. The UDQ was offered for nationwide use via the home-
page of the competent authority in 2011 together with an invitation 
to participate in the study. Still, the evaluation was limited to four 
BE of which only one was able to provide a complete set of com-
parative data for the UDQ and the DQ, allowing for regression 
analysis. Only two university BE participated, and thus it is difficult 
to predict if the UDQ has specific effects on a predominantly stu-
dent donor population. 
In conclusion, we were able to demonstrate the feasibility of the 
UDQ in this multicenter study. Most deferrals are due to medical 
treatment or conditions and ensure blood product safety and 
donor health. The subsequent higher deferral rates need to be 
monitored, and appropriate measures need to be taken to ensure 
the blood supply also in the future. The temporary deferral of indi-
viduals with a new heterosexual partner is warranted to deal with 
non-specified but increasing heterosexual risk behavior among do-
nors. Further studies, including donor perception of question-
naires and correlations with screening results of those who are de-
ferred, will be beneficial. We hope that this work motivates and 
guides future research in this area.
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